JP2023527487A5 - - Google Patents
Info
- Publication number
- JP2023527487A5 JP2023527487A5 JP2022538193A JP2022538193A JP2023527487A5 JP 2023527487 A5 JP2023527487 A5 JP 2023527487A5 JP 2022538193 A JP2022538193 A JP 2022538193A JP 2022538193 A JP2022538193 A JP 2022538193A JP 2023527487 A5 JP2023527487 A5 JP 2023527487A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrocarbyl
- substituted
- compound according
- oxaalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962949160P | 2019-12-17 | 2019-12-17 | |
| US62/949,160 | 2019-12-17 | ||
| PCT/US2020/065593 WO2021127166A1 (en) | 2019-12-17 | 2020-12-17 | Inhibitors of enl/af9 yeats |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527487A JP2023527487A (ja) | 2023-06-29 |
| JP2023527487A5 true JP2023527487A5 (cg-RX-API-DMAC10.html) | 2025-05-22 |
| JP7840851B2 JP7840851B2 (ja) | 2026-04-06 |
Family
ID=76476792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538193A Active JP7840851B2 (ja) | 2019-12-17 | 2020-12-17 | Ｅｎｌ／ａｆ９ ｙｅａｔｓの阻害剤 |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024518824A (ja) | 2021-05-13 | 2024-05-07 | ブリッジ メディシンズ | Ｅｎｌ／ａｆ９ ｙｅａｔｓのｃ結合阻害剤 |
| CN117580944A (zh) * | 2021-08-03 | 2024-02-20 | 苏州沙砾生物科技有限公司 | 一种修饰的免疫细胞及其用途 |
| US20250376473A1 (en) * | 2022-07-01 | 2025-12-11 | Cytosinlab Therapeutics Co., Ltd. | Prmts inhibitor and use thereof |
| GB202213164D0 (en) | 2022-09-08 | 2022-10-26 | Cambridge Entpr Ltd | Novel compounds, compositions and therapeutic uses thereof |
| GB202213163D0 (en) | 2022-09-08 | 2022-10-26 | Cambridge Entpr Ltd | Novel compounds, compositions and therapeutic uses thereof |
| US20260078121A1 (en) * | 2022-09-08 | 2026-03-19 | Bridge Medicines | Inhibitors of enl/af9 yeats and flt3 |
| WO2024140923A1 (zh) * | 2022-12-30 | 2024-07-04 | 苏州浦合医药科技有限公司 | Prmt5-mta抑制剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2375359C2 (ru) * | 2004-09-03 | 2009-12-10 | Юхан Корпорейшн | ПРОИЗВОДНЫЕ ПИРРОЛО[3, 2-c]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ |
| US20110015225A1 (en) * | 2008-04-01 | 2011-01-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EP2522657B1 (en) * | 2010-01-06 | 2016-08-03 | Takeda Pharmaceutical Company Limited | Indole derivative |
| EP2818472A1 (en) * | 2013-06-27 | 2014-12-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators |
| WO2022146920A1 (en) * | 2020-12-28 | 2022-07-07 | Celgene Corporation | Heterocyclic compounds and their use for parasitic diseases |
| JP2024518824A (ja) * | 2021-05-13 | 2024-05-07 | ブリッジ メディシンズ | Ｅｎｌ／ａｆ９ ｙｅａｔｓのｃ結合阻害剤 |
-
2020
- 2020-12-17 CR CR20220326A patent/CR20220326A/es unknown
- 2020-12-17 AU AU2020407589A patent/AU2020407589A1/en active Pending
- 2020-12-17 JP JP2022538193A patent/JP7840851B2/ja active Active
- 2020-12-17 WO PCT/US2020/065593 patent/WO2021127166A1/en not_active Ceased
- 2020-12-17 US US17/757,492 patent/US20230027198A1/en active Pending
- 2020-12-17 EP EP20903540.1A patent/EP4076440B1/en active Active
- 2020-12-17 CA CA3162253A patent/CA3162253A1/en active Pending
- 2020-12-17 IL IL293839A patent/IL293839A/en unknown
- 2020-12-17 BR BR112022012273A patent/BR112022012273A2/pt unknown
- 2020-12-17 KR KR1020227024539A patent/KR20220129554A/ko active Pending
- 2020-12-17 CN CN202510375451.1A patent/CN120289456A/zh active Pending
- 2020-12-17 PH PH1/2022/551529A patent/PH12022551529A1/en unknown
- 2020-12-17 MX MX2022007442A patent/MX2022007442A/es unknown
- 2020-12-17 CN CN202080096854.8A patent/CN115427035B/zh active Active
-
2022
- 2022-07-13 CO CONC2022/0009852A patent/CO2022009852A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013213260B2 (en) | Imidazopyrrolidinone compounds | |
| CA2446820C (en) | Novel pyrrole derivatives as pharmaceutical agents | |
| JP5421985B2 (ja) | Ｃｇｒｐ受容体アンタゴニスト | |
| JP2025510656A5 (cg-RX-API-DMAC10.html) | ||
| US8969341B2 (en) | Pyrazolopyrrolidine compounds | |
| AU2004253690B2 (en) | Pyrrolodihydroisoquinolines as PDE10 inhibitors | |
| JP2024517695A5 (cg-RX-API-DMAC10.html) | ||
| EP2855483A1 (en) | Pyrrolopyrrolidinone compounds | |
| HK1245780A1 (en) | Imidazopyrrolidinone compounds | |
| JP2017530167A5 (cg-RX-API-DMAC10.html) | ||
| RU2012131129A (ru) | Соединения замещенного n-(1н-индазол-4-ил)имидазол[1,2-а]-3-карбоксамида как ингибиторы cfms | |
| JP2014528479A5 (cg-RX-API-DMAC10.html) | ||
| JP2019536785A5 (cg-RX-API-DMAC10.html) | ||
| EA004542B1 (ru) | 1, 2-аннелированные производные хинолина | |
| WO2015015318A4 (en) | Novel quinazolinones as bromodomain inhibitors | |
| JP2018522869A5 (cg-RX-API-DMAC10.html) | ||
| ES2331519T3 (es) | Derivados de pirrolo-dihidroisoquinolina como inhibidores de pde10. | |
| JP2019522628A5 (cg-RX-API-DMAC10.html) | ||
| JP2025106358A5 (cg-RX-API-DMAC10.html) | ||
| CA2489452A1 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
| KR20220012913A (ko) | 융합 복소환 유도체 | |
| JPWO2023132369A5 (cg-RX-API-DMAC10.html) | ||
| JP2024506047A5 (cg-RX-API-DMAC10.html) | ||
| EP3083588A1 (en) | Aromatic heterocyclic compounds and their application in pharmaceuticals | |
| RU2024120388A (ru) | Комбинация блокатора каналов task1/3 с антагонистом рецептора p2x3 для лечения апноэ во сне |